Elanco is seeking a Senior Research Scientist for its Non-Clinical Development team. This non-laboratory-based role drives pharmacological strategies in early drug development to profile new chemical and biological entities and advanced therapies. The role focuses on mitigating clinical development risks by bridging in vitro screening and clinical efficacy, and represents translational pharmacology in cross-functional teams. The scientist applies expertise in target pharmacology and therapeutic options to advance pipeline assets and translate findings into clinical development scenarios. The position designs and coordinates translational pharmacological studies; analyzes mechanisms of action, target biology, and disease pathophysiology; and oversees early in vivo profiling programs and external research activities. It defines biomarker strategies and partners with Safety and DMPK experts on PK/PD approaches. The role also performs reverse-translational analyses of clinical data across species, evaluates study failures and development implications, and identifies potential new indications for portfolio compounds. As a subject matter expert in a matrix organization, the scientist collaborates with external academic and industry partners, provides scientific guidance to Marketing, Business Development, and project teams through launch, and stays current with scientific publications and developments in animal health. The position is based at Elanco’s global headquarters in Indianapolis, Indiana, in a hybrid environment, with up to 30% global travel required.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree